cached image

William E. Fantegrossi, Ph.D.

Affiliations: 
Pharmacology & Toxicology University of Arkansas for Medical Sciences, United States 
Area:
behavioral pharmacology, emerging drugs of abuse, hallucinogens, drug discrimination, drug self-administration
Website:
http://pharmtox.uams.edu/faculty/primary-faculty/william-e-fantegrossi-ph-d/
Google:
"William Fantegrossi"
Mean distance: 15.08 (cluster 19)
 
SNBCP
Cross-listing: Chemistry Tree

Parents

Sign in to add mentor
Stanley J. Weiss research assistant 1992-1994 American University, Washington DC
Raymond F. Genovese research assistant 1994-1995 Walter Reed
Anthony L. Riley research assistant 1995-1996 American University, Washington DC
John R. Glowa research assistant 1995-1997 UAMS
James H. Woods grad student 1997-2002 University of Michigan
 (Behavioral and pharmacological characterization of 3,4-methylenedioxymethamphetamine, its enantiomers, and related compounds.)
Michael R. Kilbourn post-doc 2002-2004 University of Michigan Medical School
Leonard L. Howell research scientist 2004-2007 Emory University / Yerkes National Primate Center

Children

Sign in to add trainee
Prescott Tarn Leach research assistant 2003-2004 University of Michigan
Naoki Murai research assistant 2005-2007 Emory University / Yerkes National Primate Center
William S. Hyatt grad student 2015- UAMS
Lauren N. Russell grad student 2016- UAMS
Cathryn Wilson grad student 2016- UAMS
Kyle Urquhart grad student 2017- UAMS
James E. Goeders grad student 2003-2003 Emory University / Yerkes National Primate Center (Chemistry Tree)
Ken Taro Wakabayashi grad student 2004-2004 University of Michigan
Kevin S. Murnane grad student 2005-2007 Emory University / Yerkes National Primate Center
Andrew P. Norwood grad student 2014 UAMS
Michael Berquist post-doc 2016- UAMS
Sherrica Tai post-doc 2014-2016 UAMS
Lisa K. Brents research scientist 2016- UAMS

Collaborators

Sign in to add collaborator
Brenda M. Gannon collaborator UAMS
Kenner C. Rice collaborator 1996- NIH
Thomas E. Prisinzano collaborator 1999- University of Kansas School of Pharmacy (Chemistry Tree)
Jerrold C. Winter collaborator 2004- UAMS
Matthew P. Galloway collaborator 2007- Wayne State Univ Sch Med
Paul L. Prather collaborator 2009- UAMS
S. Michael Owens collaborator 2015- UAMS
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McClenahan SJ, Gunnell MG, Owens SM, et al. (2020) Active vaccination reduces reinforcing effects of MDPV in male Sprague-Dawley rats trained to self-administer cocaine. Psychopharmacology
Hay CE, Ewing LE, Hambuchen MD, et al. (2020) The development and characterization of an scFv-Fc fusion based gene therapy to reduce the psychostimulant effects of methamphetamine abuse. The Journal of Pharmacology and Experimental Therapeutics
Hyatt WS, Hirsh CE, Russell LN, et al. (2020) The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats. Behavioural Pharmacology
Jones S, Yarbrough AL, Fantegrossi WE, et al. (2020) Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135). Pharmacology Research & Perspectives. 8: e00561
Berquist MD, Leth-Petersen S, Kristensen JL, et al. (2020) In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation. Drug and Alcohol Dependence. 208: 107850
Berquist MD, Leth-Petersen S, Kristensen JL, et al. (2019) Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization. Psychopharmacology
Hyatt WS, Berquist MD, Chitre NM, et al. (2019) Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats. Behavioural Pharmacology
Griffin BA, Caperton CO, Russell LN, et al. (2019) exposure to norbuprenorphine, a major metabolite of buprenorphine, induces fetal opioid dependence and leads to neonatal opioid withdrawal syndrome. The Journal of Pharmacology and Experimental Therapeutics
Ford BM, Cabanlong CV, Tai S, et al. (2019) Reduced tolerance and asymmetrical cross-tolerance to effects of indole quinuclidinone analogue PNR-4-20, a G protein biased CB1R agonist in mice: comparisons with Δ9-THC and JWH-018. The Journal of Pharmacology and Experimental Therapeutics
Jones S, Yarbrough AL, Shoeib A, et al. (2019) Enzymatic Analysis of Glucuronidation of Synthetic Cannabinoid 1-Naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22). Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-25
See more...